Skip to main content
Midas Edge

MANGOCEUTICALS INC

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

MGRX$0.20+1.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit)

MANGOCEUTICAL, INC. AND SUBSIDIARY

Condensed Consolidated Statement of Changes in Stockholders’ Equity

For the Three and Nine Months Ended September 30, 2024 and 2023

Preferred B Stock · Preferred C Stock · Common Stock · Stock · Subscriptions · Additional Paid-in · Accumulated · Total Comprehensive · Non- Controlling · Stockholders’ Equity
Shares · Amount · Shares · Amount · Shares* · Amount · Warrants · Receivable · Capital · Deficit · Loss · Interest · (Deficit)
Balance, December 31, 2022-$--$-891,00089$-$-$2,629,696$(2,015,756)$-$-$614,029
Issuance of common stock for services----46,6675--699,995---700,000
Issuance of common stock for cash----83,3338--4,999,992---5,000,000
Imputed interest--------1,760---1,760
Options and warrants vested for services--------64,271---64,271
Net loss---------(2,560,885)--(2,560,885)
Balance, March 31, 2023-$--$-1,021,000$102$-$-$8,395,714$(4,576,641)$-$-$3,819,175
Issuance of common stock for services----25,0003--386,997---387,000
Issuance of common stock for cash----68,3007--1,024,493---1,024,500
Imputed interest--------(8,233)---(8,233)
Options and warrants vested for services--------64,271---64,271
Net loss---------(2,284,025)--(2,284,025)
Balance, June 30, 2023-$--$-1,114,300$112$-$-$9,863,242$(6,860,666)$-$-$3,002,688
Issuance of common stock for services----5,0005--84,747---84,752
Options and warrants vested for services--------66,842---66,842
Net loss---------(1,799,460)--(1,799,460)
Balance, September 30, 2023-$--$-1,119,300$117$-$-$10,014,831$(8,660,126)$-$-$1,354,822
Balance, December 31, 2023-$--$-1,427,967$148$-$-$12,002,779$(11,228,173)$-$-$774,754
Issuance of common stock for services----106,66711--416,489---416,500
Issuance of common stock for cash----40,0004--179,996---180,000
Options and warrants vested for services--------37,965---37,965
Translation adjustment----------(70)-(70)
Net loss---------(2,367,581)-(36)(2,367,617)
Balance, March 31, 2024-$--$-1,574,634163$-$-12,637,229(13,595,754)(70)(36)(958,468)
Issuance of preferred stock B for cash2,500-----34,300(1,000,000)2,465,700---1,500,000
Amortization of discount on preferred stock--------222,678---222,678
Issuance of preferred stock C for patent acquisition--980,00098--14,209,902---14,210,000
Issuance of common stock for services----176,15418--808,136---808,154
Issuance of common stock for cash----63,3336388,264---388,270
Conversion of preferred stock B for common stock(355)-------(390,500)---(390,500)
Issuance of common stock for conversion of preferred stock B----128,24313--390,487390,500
Options and warrants vested for services--------50,980---50,980
Translation adjustment--------(1,096)-(1,096)
Net loss-------(2,390,979)-(340)(2,391,319)
Balance, June 30, 20242,145$-980,000$981,942,364$200$34,300$(1,000,000)$30,782,876$(15,986,733)$(1,166)$(376)$13,829,199
Issuance of preferred stock B for cash-------750,000----750,000
Amortization of discount on preferred stock--------241,620---241,620
Issuance of common stock for services----106,33311--458,850---458,861
Conversion of preferred stock B for common stock(285)-------(313,500)---(313,500)
Issuance of common stock for conversion of preferred stock B----85,9289--313,491---313,500
Options and warrants vested for services--------108,758---108,758
Reverse stock split rounding adjustment-----(7)--252---245
Translation adjustment----------(497)-(497)
Net loss---------(1,999,233)-(461)(1,999,694)
Balance, September 30, 20241,860$-980,000$982,134,625$213$34,300$(250,000)$31,592,347$(17,985,966)$(1,663)$(837)$13,388,492
*Shares have been retroactively adjusted to reflect the decreased number of shares resulting from a 1 for 15 reverse stock split
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.